Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation

Chinese Medical Journal

Volumn 124, Issue 19, 2011, Pages 3189-3191

  Zhuang, Jun Ling ^a   Jiang, Qing Wei ^a   Xu, Ying ^a   Wang, Shu Jie ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Disseminated intravascular coagulation; Hemaphagocytic lymphohistiocytosis; Recombinant factor VIIa

Indexed keywords

ANTIPYRETIC AGENT; AZITHROMYCIN; DEXAMETHASONE; ETOPOSIDE; FIBRINOGEN; IMIPENEM; IMMUNOGLOBULIN; MOXIFLOXACIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SOMATOSTATIN; TRANEXAMIC ACID;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CAUSE OF DEATH; DISEASE DURATION; DISSEMINATED INTRAVASCULAR CLOTTING; ECCHYMOSIS; EPISTAXIS; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEMATOCHEZIA; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMOSTASIS; HUMAN; INTESTINAL BLEEDING; LABORATORY TEST; LIVER FUNCTION TEST; LYMPHOMA; MYALGIA; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; PANCYTOPENIA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROPERITONEAL HEMORRHAGE; SEPTIC SHOCK; SINGLE DRUG DOSE; VOMITING;

ADULT; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR VIIA; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; RECOMBINANT PROTEINS;

EID: 80053501879     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.19.043     Document Type: Article

References (9)

1. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
2. Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cellinduced apoptosis. Blood 2002; 100: 2891-2898.
3. Henter JI, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-2922.
4. Janka GE, Schneider EM. Modern management of children with hemophagocytic lymphohistiocytosis. Br J Hematol 2004; 124: 4-14.
5. Lisman T, De Groot PHG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003; 1: 1138-1139.
6. Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost 1999; 82: 531-539.
7. Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia a meta-analysis of randomized control trials. Ann Surg 2008; 248: 61-68.
8. Celkan T, Alhaj S, Civilibal M, Elicevik M. Control of bleeding associated with hemophagocytic syndrome in children: an audit of the clinical use of recombinant acitivated factor VII. Pediatr Hematol Oncol 2007; 24: 117-121.
9. Miller CG, Stringer MD, Sugarman I, Richards M. The use of recombinant factor VIIa for bleeding in paediatric practice. Hemophilia 2005; 11: 171-174.